1. What data in particular will be shared?
   Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response -  Statistical Analysis Plan
   Response - Informed Consent Form
   Response - Clinical Study Report
   Response -  Analytic Code
   
   
3. Who will be able to view these files?
   Response (Others) -  Peers involved in the manuscript review for publication and any regulatory authority


4. For what types of analyses will this data be available?
   Response - To achieve aims in the approved proposal.
   


5. By what mechanism will data be made available?
   Response (Others) -  The data will be sent on written request by the Editor of the Journal or Head of the regulatory authority


6. For how long will this data be available start date provided 25-01-2021 and end date provided 25-01-2027?
   Response - Beginning 9 months and ending 36 months following article publication.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - NIL

Informed consent will be obtained from all participants before enrolling into the study. Data regarding time of sustainment of burns and cause of burns will be recorded. Information regarding pre-existing illness/comorbidities will be collected. Alcohol consumption and Tobacco usage history will be collected. Area of the burns is measured using Modified Lund and Browder chart and Palmar method, and depth of the wound will be mapped pictorially. Area of the Partial thickness burn wound Allografted will be measured postoperatively. After allografting wound will be evaluated on POD 4, POD 10, POD 15 and POD 21 or on the day of discharge (which one of the either is the earliest) to look for healing. Area of the wound  taken up for early Auto grafting, if the wound is considered non healing after Allografting, will be measured and on which postoperative day after allografting  the decision made by the treating unit and the POD on which the wound is Autografted will be noted. Data regarding lab parameters such as Haemoglobin, Serum electrolytes, Serum Total Proteins, Serum albumin and Blood culture, wound culture sensitivity reports will be collected during the course of study period. Body weight of the patient will be measured at the time of admission and weekly after Allografting. Pain scoring will be done, from age 10 yrs to 75 yrs, at the time of admission on POD 4, POD 10, POD 15 and POD 21 or on the day of discharge (which one of the either is the earliest). Data regarding blood product transfusions, Albumin infusion and electrolyte imbalance corrections (post Allografting) will be collected. Information regarding the illness/Disease/comorbidities found on evaluation by the treating unit during the course of study will be collected. Percentage area of the allografted wound healed will be measured at the time of discharge. Feedback will be collected on follow up regarding nature of scar after 1week, 1month, 2months, 3 months, after discharge. Statistics will be provided at the end of study.